Psychedelics research gains support from the Trump administration for treating PTSD and mental health conditions, with Veterans Affairs exploring treatments that show promise in clinical trials.

At a panel at CTO West Coast, experts from biopharmaceutical companies outlined innovative strategies to shape the future of ...

FAU's innovative deep learning model offers accurate, real-time nystagmus diagnosis, optimizing telehealth and improving ...

Research findings suggest that a new blood test for Alzheimer’s disease has shown promise in accurately identifying people ...

A guide to the recommended hours of sleep for women and the factors that effect their ability to get quality rest ...

Luton, Bedfordshire, United Kingdom, June 05, 2025 (GLOBE NEWSWIRE) -- The global pediatric glioma drugs market is poised for substantial growth, with an estimated value of approximately USD 5 billion ...

Specialty televisits remain common in the Veterans Health Administration following the COVID-19 pandemic, suggesting they will remain an important ongoing care modality for many patients.

BioNet and Bio Farma partner to develop TdaP vaccines for ASEAN region, targeting 10-15 million doses annually worth $200 ...

An annual review of clinical trials for Alzheimer's disease highlights a growing number of active trials—and drugs—in the ...

The company has received FDA Breakthrough Device Designation for its Blindsight vision restoration system and a speech ...

Bildnachweis: BIO Deutschland, BioM, EY, BCG, Biomed X, VC Magazin, Pixabay. In principle, Germany has excellent prerequisites, but does not currently play a leading role internationally in the life ...

LUND, SE / ACCESS Newswire / June 3, 2025 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) - Spago Nanomedical AB (publ) announced today that the Data Monitoring Committee (DMC) recommends the ongoing ...